COVID-19 - December 10, 2020
Recipharm to formulate, fill and finish Moderna’s vaccine candidate
Recipharm has signed a letter of intent with Moderna, a U.S. based biotech company, to formulate, fill and finish mRNA-1273, Moderna’s COVID-19 vaccine candidate. The activity will be performed in Recipharm’s drug product manufacturing facility located in Monts, France. Recipharm has reserved capacity to support the anticipated demand for the vaccine and is already in […]
COVID-19 - December 9, 2020
Interim analysis results from AstraZeneca-Oxford Phase III trials
Results of an interim analysis of the Phase III programme conducted by Oxford University with AZD1222, peer-reviewed and published in The Lancet, demonstrated that the vaccine is safe and effective at preventing symptomatic COVID-19 and that it protects against severe disease and hospitalisation. The interim analysis for efficacy was based on 11,636 participants accruing 131 symptomatic […]
COVID-19 - December 5, 2020
Almost a quarter of COVID-19 patients did not meet the criteria of characteristic symptoms
A new study conducted by a research team from the Landspítali University Hospital and the University of Iceland on the frequency and development of symptoms among COVID-19 patients during the first wave in Iceland suggests that almost a quarter would not have been diagnosed with the disease or would have had a delayed diagnosis if […]
COVID-19 - December 4, 2020
Pfizer and BioNTech achieve first authorization in the world for a COVID-19 vaccine
Pfizer and BioNTech have announced that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the UK has granted a temporary authorization for emergency use for their mRNA vaccine (BNT162b2), against COVID-19. This constitutes the first Emergency Use Authorization following a worldwide Phase 3 trial of a vaccine to help fight the pandemic. Pfizer and […]
COVID-19 - December 1, 2020
COVID-19 vaccines: CEPI steps up
Since launching at Davos in 2017, an Oslo-based global organization has been accelerating pandemic preparations. Years before COVID-19 appeared, the Coalition for Epidemic Preparedness Innovations (CEPI) began working to make vaccine development – including for coronaviruses – faster and less of a financial burden. CEPI is a global nonprofit, supported by public and private funders, […]
COVID-19 - December 1, 2020
Valneva Sweden prepares for production of COVID-19 vaccines
Valneva Sweden’s Solna facility is ramping up its ‘fill and finish’ capacity to accommodate expanding production of the VLA2001 COVID-19 vaccine candidate. This expansion of production capacity will help strengthen Sweden’s future pandemic preparedness as well as being critical with helping solve the current crisis, the company states. “We have had our factory here for […]
